Orphenadrine Citrate
Product Images NDC 33358-274

2 FDA label images from Rxchange Co. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 33358-274). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rxchange Co., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (4ed1b591 Figure 01)

Chemical Structure (4ed1b591 Figure 01)
Chemical structure diagram of Orphenadrine Citrate showing the molecular arrangement of its active components.*
FDA Label Image

Rxchange Co. (33358-274-60) Orphenadrine Citrate Er, 60 Er Tablets (Rxchange Co. (33358 274 60) Orphenadrine Citrate Er, 60 Er Tablets)

Rxchange Co. (33358-274-60) Orphenadrine Citrate Er, 60 Er Tablets (Rxchange Co. (33358 274 60) Orphenadrine Citrate Er, 60 Er Tablets)
Orphenadrine ER 100mg, extended-release tablets, 60 count bottle from RxChange Co. The label includes item and lot numbers, expiration date, and usage instructions. Tablets are round, white to off-white with 'NC4' on one side and plain on the other. The product is to be stored at controlled room temperature and dispensed in a tight/light resistant container.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.